Cingulate Inc. (NASDAQ:CINGW) Short Interest Down 66.1% in May

Cingulate Inc. (NASDAQ:CINGW) was the recipient of a large decline in short interest during the month of May. As of May 15th, there was short interest totaling 3,796 shares, a decline of 66.1% from the April 30th total of 11,190 shares. Based on an average daily trading volume, of 16,655 shares, the short-interest ratio is currently 0.2 days.

Cingulate Price Performance

Shares of Cingulate stock traded up $0.01 during midday trading on Friday, reaching $0.04. The company had a trading volume of 111,027 shares, compared to its average volume of 42,855. The stock has a fifty day moving average price of $0.03 and a 200 day moving average price of $0.05. Cingulate has a fifty-two week low of $0.02 and a fifty-two week high of $0.18.

About Cingulate

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.